Answers are grounded in this paper and cite their sources.
A patient-linked in-vitro model system to investigate the interplay of cardiac and vascular cells offers opportunities to understand pathogenesis. Here we establish that novel 3D structure of iPSC-derived vascularised cardiac organoids (VCO), originated from donors with type 2 diabetes mellitus (T2DM) demonstrate pronounced mechanistic, cellular and mitochondrial dysfunction when compared to non-diabetic counterparts. Integrated RNA sequencing, functional assays, and RT-PCR analyses identified novel molecular signatures indicative of mitochondrial dysfunction and impaired mitophagy. Notably, these analyses demonstrated a significant upregulation of TINF2, a telomeric protein and key components of the shelterin complex. To our knowledge, the involvement of TINF2 has not previously been reported in cardiac or vascular-specific cell types, nor altered in T2DM. Transgenic targeting of TINF2 was associated with reversing of the targets of T2DM-related mitochondrial dysfunction and was associated with restoring of mitophagy. Our findings reveal the potentially vital role of the TINF2 protein in T2DM-associated mitochondrial dysfunction and the potential for re-targeting mitophagy for the treatment of T2DM.
No takes yet. Share an insight, caveat, or question.
Kuburas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: